Influence of 4 preservation solutions on ICU stay, graft and patient survival following liver transplantation

Yang, 2017, Hepatocellular carcinoma is the most common indication for liver transplantation and placement on the waitlist in the United States, Clin Gastroenterol Hepatol, 15, 767, 10.1016/j.cgh.2016.11.034 Adam, 2015, Compared efficacy of preservation solutions in liver transplantation: a long-term graft outcome study from the European Liver Transplant Registry, Am J Transplant, 15, 395, 10.1111/ajt.13060 Kim, 2018, OPTN/SRTR 2016 Annual Data Report: Liver, Am J Transplant, 18, 172, 10.1111/ajt.14559 Rapport de l’Agence de la biomédecine. 2016. https://www.agence-biomedecine.fr/annexes/bilan2016/donnees/organes/05-foie/synthese.htm. Olthoff, 2010, Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors, Liver Transpl, 16, 943, 10.1002/lt.22091 Durand, 2008, Report of the Paris consensus meeting on expanded criteria donors in liver transplantation, Liver Transpl, 14, 1694, 10.1002/lt.21668 Bral, 2017, Preliminary single-center Canadian experience of human normothermic ex vivo liver perfusion: results of a clinical trial, Am J Transplant, 17, 1071, 10.1111/ajt.14049 Ravikumar, 2016, Liver transplantation after ex vivo normothermic machine preservation: A phase 1 (first-in-man) clinical trial, Am J Transplant, 16, 1779, 10.1111/ajt.13708 Selzner, 2016, Normothermic ex vivo liver perfusion using steen solution as perfusate for human liver transplantation: First North American results, Liver Transpl, 22, 1501, 10.1002/lt.24499 Hoyer, 2016, Controlled oxygenated rewarming of cold stored livers prior to transplantation: First clinical application of a new concept, Transplantation, 100, 147, 10.1097/TP.0000000000000915 van Rijn, 2017, Dual hypothermic oxygenated machine perfusion in liver transplants donated after circulatory death, Br J Surg, 104, 907, 10.1002/bjs.10515 von Elm, 2007, The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies, Lancet, 370, 1453, 10.1016/S0140-6736(07)61602-X Savier, 2015, First experience of liver transplantation with type 2 donation after cardiac death in France, Liver Transpl, 21, 631, 10.1002/lt.24107 Heidenhain, 2010, Incidence of and risk factors for ischemic-type biliary lesions following orthotopic liver transplantation, Transpl Int, 23, 14, 10.1111/j.1432-2277.2009.00947.x Mangus, 2008, Comparison of histidine-tryptophan-ketoglutarate solution and University of Wisconsin solution in extended criteria liver donors, Liver Transpl, 14, 365, 10.1002/lt.21372 Franco-Gou, 2007, New preservation strategies for preventing liver grafts against cold ischemia reperfusion injury, J Gastroenterol Hepatol, 22, 1120, 10.1111/j.1440-1746.2006.04495.x Ben, 2006, Preservation of steatotic livers in IGL-1 solution, Liver Transpl, 12, 1215, 10.1002/lt.20788 Brisson, 2017, Impact of graft preservation solutions for liver transplantation on early cytokine release and postoperative organ dysfunctions. A pilot study, Clin Res Hepatol Gastroenterol, 41, 564, 10.1016/j.clinre.2016.12.011 Thuillier, 2010, Effect of polyethylene glycol-based preservation solutions on graft injury in experimental kidney transplantation, Br J Surg Thuillier, 2011, Improving long-term outcome in allograft transplantation: role of ionic composition and polyethylene glycol, Transplantation, 91, 605, 10.1097/TP.0b013e3182090fa3 O’Callaghan, 2014, The effect of preservation solutions for storage of liver allografts on transplant outcomes: a systematic review and meta-analysis, Ann Surg, 260, 46, 10.1097/SLA.0000000000000402 Nashan, 2015, Regarding “Compared efficacy of preservation solutions in liver transplantation: A long-term graft outcome study from the European Liver Transplant Registry”, Am J Transplant, 15, 3272, 10.1111/ajt.13513 Adam, 2015, Reply to letter regarding “Compared efficacy of preservation solutions in liver transplantation: A long-term graft outcome study from the European Liver Transplant Registry”, Am J Transplant, 15, 3274, 10.1111/ajt.13512 Rana, 2017, Liver transplant length of stay (LOS) index: a novel predictive score for hospital length of stay following liver transplantation, Clin Transplant, 31 Gurusamy, 2008, Ischaemic preconditioning for liver transplantation, Cochrane Database Syst Rev, CD006315 Levesque, 2011, Impact of reversible cardiac arrest in the brain-dead organ donor on the outcome of adult liver transplantation, Liver Transpl, 17, 1159, 10.1002/lt.22372 Holowko, 2014, Reliability of frozen section in the assessment of allograft steatosis in liver transplantation, Transplant Proc, 46, 2755, 10.1016/j.transproceed.2014.09.102 D’Alessandro, 2010, Frozen-section diagnosis in donor livers: error rate estimation of steatosis degree, Transplant Proc, 42, 2226, 10.1016/j.transproceed.2010.05.033 Salvalaggio, 2013, A proposal to grade the severity of early allograft dysfunction after liver transplantation, Einstein (Sao Paulo), 11, 23, 10.1590/S1679-45082013000100006 Braat, 2012, The Eurotransplant donor risk index in liver transplantation: ET-DRI, Am J Transplant, 12, 2789, 10.1111/j.1600-6143.2012.04195.x